NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,265,000 | -30.8% | 938,235 | 0.0% | 0.02% | -37.5% |
| Q1 2018 | $4,719,000 | -15.9% | 938,235 | 0.0% | 0.04% | -18.4% |
| Q4 2017 | $5,611,000 | -27.0% | 938,235 | 0.0% | 0.05% | -21.0% |
| Q3 2017 | $7,684,000 | +109.5% | 938,235 | +168.1% | 0.06% | +93.8% |
| Q2 2017 | $3,668,000 | – | 350,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 4,256,526 | $11,493,000 | 2.10% |
| Vivo Capital, LLC | 6,619,190 | $17,872,000 | 1.80% |
| Novo Holdings A/S | 4,703,720 | $12,700,000 | 1.01% |
| Rock Springs Capital Management LP | 1,800,000 | $4,860,000 | 0.18% |
| Orbimed Advisors | 4,644,600 | $12,540,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 212,500 | $443,000 | 0.09% |
| Granahan Investment Management | 247,276 | $668,000 | 0.04% |
| WEDBUSH SECURITIES INC | 92,050 | $249,000 | 0.03% |
| Laurion Capital Management LP | 419,670 | $1,133,000 | 0.01% |
| SECTORAL ASSET MANAGEMENT INC | 38,255 | $103,000 | 0.01% |